Department of Neurology,Medical University of Vienna,Vienna,Austria.
Center for Medical Statistics, Informatics, and Intelligent Systems,Medical University of Vienna,Vienna,Austria.
Int Psychogeriatr. 2019 Apr;31(4):537-549. doi: 10.1017/S1041610218001114. Epub 2018 Sep 21.
ABSTRACTObjective:Recent studies have tried to find a reliable way of predicting the development of Alzheimer´s Disease (AD) among patients with mild cognitive impairment (MCI), often focusing on olfactory dysfunction or semantic memory. Our study aimed to validate these findings while also comparing the predictive accuracy of olfactory and semantic assessments for this purpose.
Six hundred fifty patients (median age 68, 58% females) including controls, SCD (subjective cognitive decline), non-amnestic MCI (naMCI), amnestic MCI (aMCI), and AD patients were tested for olfactory dysfunction by means of odor identification testing and semantic memory. Of those 650 patients, 120 participants with SCD, naMCI, or aMCI at baseline underwent a follow-up examination after two years on average. Of these 120 patients, 12% had developed AD at follow-up (converters), while 88% did not develop AD at follow-up (non-converters).
Analysis showed a significant difference only for initial olfactory identification between converters and non-converters. Sensitivity of impairment of olfactory identification for AD prediction was low at 46.2%, although specificity was high at 81.9%. Semantic memory impairment at baseline was not significantly related to AD conversion, although, when naming objects, significant differences were found between AD patients and all other groups and between naMCI and aMCI patients compared to controls and SCD patients.
Objective olfactory assessments are promising instruments for predicting the conversion to AD among MCI patients. However, due to their low sensitivity and high specificity, a combination with other neuropsychological tests might lead to an improved predictive accuracy. Further longitudinal studies with more participants are required to investigate the usefulness of semantic memory tests in this case.
最近的研究试图为轻度认知障碍(MCI)患者中阿尔茨海默病(AD)的发展找到一种可靠的预测方法,通常侧重于嗅觉功能障碍或语义记忆。我们的研究旨在验证这些发现,同时比较嗅觉和语义评估在这方面的预测准确性。
650 名患者(中位数年龄 68 岁,58%为女性),包括对照组、SCD(主观认知下降)、非遗忘性 MCI(naMCI)、遗忘性 MCI(aMCI)和 AD 患者,通过嗅觉识别测试和语义记忆测试来测试嗅觉功能障碍。在这 650 名患者中,120 名基线时有 SCD、naMCI 或 aMCI 的患者在平均两年后进行了随访检查。在这 120 名患者中,12%在随访时发展为 AD(转化者),而 88%在随访时未发展为 AD(非转化者)。
分析显示,仅在转化者和非转化者之间,初始嗅觉识别存在显著差异。嗅觉识别受损对 AD 预测的敏感性较低,为 46.2%,尽管特异性较高,为 81.9%。基线时的语义记忆障碍与 AD 转化无显著相关性,尽管在命名物体时,AD 患者与所有其他组之间以及与对照组和 SCD 患者相比,naMCI 和 aMCI 患者之间存在显著差异。
客观的嗅觉评估是预测 MCI 患者向 AD 转化的有前途的工具。然而,由于其敏感性低、特异性高,与其他神经心理学测试相结合可能会提高预测准确性。需要更多参与者的进一步纵向研究来探讨语义记忆测试在这种情况下的有用性。